11/15
Holly Auer
Penn Medicine Physicians Receive Five-Year, $7.5 Million Grant for Breast Cancer Screening Research
University of Pennsylvania researchers have received a five-year, $7.5 million grant from the National Cancer Institute (NCI) to create the Penn Center for Innovation in Personalized Breast Cancer Screening (PCIPS), dedicated to studying emerging methods of breast cancer detection.
Holly Auer ・
Modified "Serial Killer" T Cells Obliterate Lymphocytic Leukemia Tumors, Penn Researchers Report
(PHILADELPHIA) -- In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineer
Holly Auer ・
Penn Study: Black Cardiac Arrest Patients More Apt to Be Admitted to Hospitals With Lowest Survival Rates
PHILADELPHIA – Black cardiac arrest victims are more likely to die when they’re treated in hospitals that care for a large black population than when they’re brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine.
Holly Auer ・
Targeted Drug Plus Malaria Pill Serve a 1-2 Punch in Cancer Patients, Penn Study Shows
Researchers at the University of Pennsylvania School of Medicine may have found a way to turn an adaptive cellular response into a liability for cancer cells. When normal cells are starved for food, they chew up existing proteins and membranes to stay alive.
Holly Auer ・
Penn Researchers Uncover Novel Immune Therapy for Pancreatic Cancer
Researchers at the University of Pennsylvania’s Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer’s scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially.
Holly Auer ・
Weightlifting Slashes Lymphedema Risk After Breast Cancer Treatment
(SAN ANTONIO) -- Weightlifting may play a key role in a program to prevent the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine.
Holly Auer ・
Personalized Vaccine for Lymphoma Patients Extends Disease-Free Survival by Nearly Two Years
(ORLANDO, Fla.) –A personalized vaccine is a powerful therapy to prevent recurrence among certain follicular lymphoma patients, according to the latest results of ongoing research led by the University of Pennsylvania School of Medicine.
Holly Auer ・
Penn Study: Hospital CPR Quality Is Worse at Night
CHICAGO -- CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.
Holly Auer ・
Breast Cancer Survivors Often Rate Post-Treatment Breast Appearance Only “Fair”
SAN DIEGO -- A third of breast cancer survivors who received the breast-conserving treatments lumpectomy and radiation rate the appearance of their post-treatment breast as only “fair” or “poor” in comparison to their untreated breast, according to a new University of Pennsylvania School of Medicine study that will be presented today at the 52nd Annual M
Holly Auer ・
Targeted Radiation Therapy Minimizes GI Side Effects for Prostate Cancer Patients, Penn Study Shows
SAN DIEGO -- Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine.
Holly Auer ・